Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

GSK2245035

Generic Name: GSK2245035

Drug Type: Small Molecule

Chemical Formula: C_₂₀H_₃₄N_₆O_₂

CAS Number: 1207629-49-9

Unique Ingredient Identifier: 5L3SX16QBQ

Overview

GSK2245035 is under investigation in clinical trial NCT02833974 (Effect of the GSK2245035 on the Allergen-induced Asthmatic Response).

Background

GSK2245035 is under investigation in clinical trial NCT02833974 (Effect of the GSK2245035 on the Allergen-induced Asthmatic Response).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma

Phase 2

Withdrawn

Posted: 2018/10/16

Sponsor:GlaxoSmithKline

ID:NCT03707678

Effect of the GSK2245035 on the Allergen-induced Asthmatic Response

Phase 2

Completed

Posted: 2016/07/15

Sponsor:GlaxoSmithKline

ID:NCT02833974

To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies

Phase 2

Completed

Posted: 2013/02/11

Sponsor:GlaxoSmithKline

ID:NCT01788813

A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies

Phase 2

Completed

Posted: 2012/05/30

Sponsor:GlaxoSmithKline

ID:NCT01607372

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy